tradingkey.logo

Cigna Group

CI
292.050USD
+7.370+2.59%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
76.94BCap. mercado
13.17P/E TTM

Más Datos de Cigna Group Compañía

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Información de Cigna Group

Símbolo de cotizaciónCI
Nombre de la empresaCigna Group
Fecha de salida a bolsaApr 01, 1982
Director ejecutivoCordani (David M)
Número de empleados73500
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 01
Dirección900 Cottage Grove Road
CiudadBLOOMFIELD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal06002
Teléfono18602266000
Sitio Webhttps://www.thecignagroup.com/
Símbolo de cotizaciónCI
Fecha de salida a bolsaApr 01, 1982
Director ejecutivoCordani (David M)

Ejecutivos de Cigna Group

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-26527.00%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+901.00%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+638.00%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+638.00%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+638.00%
Ms. Neesha Hathi
Ms. Neesha Hathi
Independent Director
Independent Director
3.37K
+638.00%
Ms. Ann M. Dennison
Ms. Ann M. Dennison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
2.92K
+2920.00%
Mr. Eric J. Foss
Mr. Eric J. Foss
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-26527.00%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+901.00%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+638.00%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+638.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenues
56.05B
80.37%
Premiums
9.08B
13.02%
Fees and other revenues
4.38B
6.28%
Other revenues
233.00M
0.33%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy revenues
56.05B
80.37%
Premiums
9.08B
13.02%
Fees and other revenues
4.38B
6.28%
Other revenues
233.00M
0.33%

Estadísticas de accionistas

Actualizado: vie., 9 de ene
Actualizado: vie., 9 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
4.80%
State Street Investment Management (US)
4.60%
MFS Investment Management
4.33%
T. Rowe Price Associates, Inc.
4.14%
Otro
72.25%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
4.80%
State Street Investment Management (US)
4.60%
MFS Investment Management
4.33%
T. Rowe Price Associates, Inc.
4.14%
Otro
72.25%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.48%
Investment Advisor/Hedge Fund
29.22%
Research Firm
2.58%
Pension Fund
2.29%
Bank and Trust
1.62%
Hedge Fund
1.59%
Sovereign Wealth Fund
1.41%
Corporation
1.21%
Individual Investor
0.40%
Otro
6.21%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
2907
242.25M
91.45%
+168.59K
2025Q3
2972
242.12M
91.90%
+1.54M
2025Q2
2981
240.55M
93.84%
-5.16M
2025Q1
2971
246.39M
94.63%
-8.92M
2024Q4
2988
249.03M
93.14%
+458.77K
2024Q3
2914
248.98M
92.53%
-1.29M
2024Q2
2894
250.44M
95.06%
-5.89M
2024Q1
2849
256.08M
92.56%
-14.53M
2023Q4
2795
262.30M
92.80%
-573.37K
2023Q3
2699
263.15M
93.94%
-4.31M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
25.62M
9.59%
+27.96K
+0.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.64M
4.73%
+229.62K
+1.85%
Sep 30, 2025
State Street Investment Management (US)
12.12M
4.54%
-145.49K
-1.19%
Sep 30, 2025
MFS Investment Management
10.55M
3.95%
-863.89K
-7.57%
Sep 30, 2025
T. Rowe Price Associates, Inc.
10.90M
4.08%
+1.00M
+10.12%
Sep 30, 2025
Dodge & Cox
9.31M
3.48%
+354.62K
+3.96%
Sep 30, 2025
Fidelity Management & Research Company LLC
8.27M
3.1%
-538.79K
-6.12%
Sep 30, 2025
Sanders Capital, LLC
7.83M
2.93%
+35.15K
+0.45%
Sep 30, 2025
GQG Partners, LLC
6.79M
2.54%
+1.02M
+17.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.00M
2.25%
+39.79K
+0.67%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
7.92%
VictoryShares Free Cash Flow ETF
3.31%
Invesco Dynamic Buyback Achievers ETF
3.22%
Monarch Dividend Plus Index ETF
2.79%
TrueShares Low Volatility Equity Income ETF
2.58%
Hennessy Sustainable ETF
2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
2.16%
Brandes US Value ETF
1.9%
Bushido Capital US Equity ETF
1.89%
Davis Select US Equity ETF
1.86%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción7.92%
VictoryShares Free Cash Flow ETF
Proporción3.31%
Invesco Dynamic Buyback Achievers ETF
Proporción3.22%
Monarch Dividend Plus Index ETF
Proporción2.79%
TrueShares Low Volatility Equity Income ETF
Proporción2.58%
Hennessy Sustainable ETF
Proporción2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
Proporción2.16%
Brandes US Value ETF
Proporción1.9%
Bushido Capital US Equity ETF
Proporción1.89%
Davis Select US Equity ETF
Proporción1.86%

Dividendos

Un total de 5.74B USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 05, 2026
CI.NB Final Cash Dividend of gross USD 1.56 paid on Mar 19, 2026 going ex on Mar 05, 2026 with reinvestment option
Mar 05, 2026
Mar 19, 2026
Mar 05, 2026
Oct 22, 2025
CI.NB Final Cash Dividend of gross USD 1.51 paid on Dec 18, 2025 going ex on Dec 04, 2025 with reinvestment option
Dec 04, 2025
Dec 18, 2025
Dec 04, 2025
Jul 22, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Sep 18, 2025 going ex on Sep 04, 2025 with reinvestment option
Sep 04, 2025
Sep 18, 2025
Sep 04, 2025
Apr 23, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Jun 18, 2025 going ex on Jun 03, 2025 with reinvestment option
Jun 03, 2025
Jun 18, 2025
Jun 03, 2025
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024 with reinvestment option
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Ver más

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI